We are live on
!
Find out more
RG
Redmile Group Portfolio holdings
AUM
$1.51B
1-Year Est. Return
164.17%
This Fund
S&P 500
This Quarter
Est. Return
+64.04%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$2.61B
AUM Growth
+$301M
(+13%)
Cap. Flow
-$35.3M
Cap. Flow
% of AUM
-1.36%
Top 10 Holdings %
Top 10 Hldgs %
53.33%
Holding
82
New
6
Increased
24
Reduced
27
Closed
10
Top Buys
| 1 |
IMGN
Immunogen Inc
IMGN
|
+$114M |
| 2 |
Krystal Biotech
KRYS
|
+$66.7M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
+$24.2M |
| 4 |
Cogent Biosciences
COGT
|
+$23.6M |
| 5 |
Zimmer Biomet
ZBH
|
+$20.6M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$102M |
| 2 |
argenx
ARGX
|
+$48.6M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
+$41.1M |
| 4 |
Sarepta Therapeutics
SRPT
|
+$31.9M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$31.2M |
Sector Composition
| 1 | Healthcare | 97.02% |
| 2 | Industrials | 2.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cytosorbents Corp
CTSO
$25.1M
| – | – |
-181,639
| Closed | -$612K |
|
77
Illumina
ILMN
$28B
| – | – |
-34,434
| Closed | -$7.79M |
|
|
78
Sarepta Therapeutics
SRPT
$1.82B
| – | – |
-231,595
| Closed | -$31.9M |
|
79
The Oncology Institute
TOI
$572M
| – | – |
-318,082
| Closed | -$216K |
|
|
ISEE
80
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-4,205,206
| Closed | -$102M |
|
|
TCRR
81
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| – | – |
-658,336
| Closed | -$988K |
|
|
OSH
82
DELISTED
Oak Street Health, Inc.
OSH
| – | – |
-1,061,295
| Closed | -$41.1M |
|
Similar funds
ORI
GAI
HCMG
FMI
FCM
PP
AM
BFO